This week in Drug Discovery (18 – 22 May)
News round-up for 18 – 22 May by Bruno Quinney, Content Team at DDW.
This week, a report showed patients in Europe face barriers to patient access. Elsewhere, Wellcome prizes are facilitating research in both tropical disease and mental health.
The top stories:
Patients in Europe face barriers to medicines access
Patients in Europe are waiting longer to access medicines than patients in the US, a new report warns.
Nervous system crucial in lung cancer response, research shows
Researchers at the Francis Crick Institute have revealed that sensory nerve signals interfere with the immune system’s response to lung cancer, highlighting a previously unrecognised neuroimmune connection which could be targeted to improve responses to immunotherapy.
FDA approves hypertension treatment in landmark step
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Baxfendy (baxdrostat) in the US for the treatment of hypertension.
University of Dundee leads effort to tackle ‘cruel’ disease
The University of Dundee has revealed plans to develop therapies to tackle a deadly tropical disease.
Wellcome and Nature launch $1m mental health science prize
The Wellcome Prize for Mental Health Science has been launched in a collaboration between charitable foundation Wellcome and scientific journal Nature, offering prizes up to $1 million.
